| RS886040968 |
SLC12A2
|
Health Risk |
Likely pathogenic |
Infant onset multiple organ failure, Infant onset multiple organ failure |
| RS886040969 |
NOD2
|
Health Risk |
Pathogenic |
Behcet disease, Behcet disease |
| RS886040971 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal dysplasia type I, Trichorhinophalangeal syndrome |
| RS886040972 |
DEAF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability-epilepsy-extrapyramidal syndrome, Intellectual disability-epilepsy-extrapyramidal syndrome |
| RS886040973 |
COQ4
|
Health Risk |
Conflicting classifications of pathogenicity |
Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome, Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome |
| RS886040974 |
C1S
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, periodontal type 2 |
| RS886040975 |
C1S
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, periodontal type 2 |
| RS886040976 |
EBF3
|
Health Risk |
Likely pathogenic |
Oromandibular-limb hypogenesis spectrum, Oromandibular-limb hypogenesis spectrum |
| RS886040977 |
LRP5
|
Health Risk |
Likely pathogenic |
Osteoporosis with pseudoglioma, Osteoporosis with pseudoglioma |
| RS886040978 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHD7-related disorder |
| RS886040980 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS886040981 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS886040982 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHD7-related disorder |
| RS886040983 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS886040984 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS886040985 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS886040986 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS886040987 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS886040988 |
CHD7
|
Health Risk |
Pathogenic/Likely pathogenic |
CHARGE syndrome, Inborn genetic diseases |
| RS886040989 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS886040990 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS886040991 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHD7-related disorder |
| RS886040992 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS886040994 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS886040995 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS886040996 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHD7-related CHARGE syndrome |
| RS886040997 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS886040998 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS886041000 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS886041001 |
ERF
|
Health Risk |
Pathogenic |
Chitayat syndrome, Inborn genetic diseases |
| RS886041002 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS886041003 |
MBD5
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 1 |
| RS886041004 |
FKRP
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 |
| RS886041005 |
EDAR
|
Health Risk |
Conflicting classifications of pathogenicity |
Ectodermal dysplasia 10A, hypohidrotic/hair/nail type |
| RS886041007 |
TUBB4A
|
Health Risk |
Pathogenic |
Hypomyelinating leukodystrophy 6, Leukodystrophy |
| RS886041008 |
TUBB4A
|
Health Risk |
Likely pathogenic |
Torsion dystonia 4, Hypomyelinating leukodystrophy 6 |
| RS886041010 |
TUBB4A
|
Health Risk |
Pathogenic |
Hypomyelinating leukodystrophy 6, Hypomyelinating leukodystrophy 6 |
| RS886041011 |
TUBB4A
|
Health Risk |
Likely pathogenic |
Hypomyelinating leukodystrophy 6, Hypomyelinating leukodystrophy 6 |
| RS886041013 |
TUBB4A
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypomyelinating leukodystrophy 6, Hypomyelinating leukodystrophy 6 |
| RS886041015 |
TUBB4A
|
Health Risk |
Likely pathogenic |
Hypomyelinating leukodystrophy 6, Hypomyelinating leukodystrophy 6 |
| RS886041018 |
TUBB4A
|
Health Risk |
Likely pathogenic |
Hypomyelinating leukodystrophy 6, Hypomyelinating leukodystrophy 6 |
| RS886041019 |
TUBB4A
|
Health Risk |
Likely pathogenic |
Hypomyelinating leukodystrophy 6, Hypomyelinating leukodystrophy 6 |
| RS886041020 |
TUBB4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypomyelinating leukodystrophy 6, Hypomyelinating leukodystrophy 6 |
| RS886041021 |
TUBB4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypomyelinating leukodystrophy 6, Torsion dystonia 4 |
| RS886041022 |
TUBB4A
|
Health Risk |
Likely pathogenic |
Hypomyelinating leukodystrophy 6, Torsion dystonia 4 |
| RS886041023 |
SUN5
|
Health Risk |
Pathogenic |
Spermatogenic failure 16, Spermatogenic failure 16 |
| RS886041024 |
SUN5
|
Health Risk |
Pathogenic |
Spermatogenic failure 16, Spermatogenic failure 16 |
| RS886041025 |
SUN5
|
Health Risk |
Pathogenic |
Spermatogenic failure 16, Spermatogenic failure 16 |
| RS886041027 |
SEC63
|
Health Risk |
Pathogenic |
Polycystic liver disease 2, Polycystic liver disease 2 |
| RS886041028 |
SEC63
|
Health Risk |
Pathogenic |
Polycystic liver disease 2, Polycystic liver disease 2 |
| RS886041030 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 4, Hypertrophic cardiomyopathy 4 |
| RS886041031 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 4, Hypertrophic cardiomyopathy 4 |
| RS886041032 |
IL2RA
|
Health Risk |
Pathogenic |
Immunodeficiency due to CD25 deficiency, Immunodeficiency due to CD25 deficiency |
| RS886041033 |
POFUT1
|
Health Risk |
Pathogenic |
Dowling-Degos disease 2, Dowling-Degos disease 2 |
| RS886041034 |
SZT2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 18 |
| RS886041035 |
KIF1C
|
Health Risk |
Likely pathogenic |
Spastic ataxia 2, Hereditary spastic paraplegia |
| RS886041036 |
IKBKB
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to IKK2 deficiency, IKBKB-related disorder |
| RS886041037 |
IL2RA
|
Health Risk |
Pathogenic |
Immunodeficiency due to CD25 deficiency, Immunodeficiency due to CD25 deficiency |
| RS886041038 |
IL2RA
|
Health Risk |
Pathogenic |
Immunodeficiency due to CD25 deficiency, Immunodeficiency due to CD25 deficiency |
| RS886041039 |
RAX2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cone-rod dystrophy 11, Retinal dystrophy |
| RS886041040 |
RP1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 1, Retinal dystrophy |
| RS886041042 |
SMARCA2
|
Health Risk |
Likely pathogenic |
— |
| RS886041043 |
CARMIL2
|
Health Risk |
Pathogenic |
Combined immunodeficiency, Severe combined immunodeficiency due to CARMIL2 deficiency |
| RS886041044 |
CARMIL2
|
Health Risk |
Pathogenic |
Combined immunodeficiency, Severe combined immunodeficiency due to CARMIL2 deficiency |
| RS886041045 |
SMARCA2
|
Health Risk |
Likely pathogenic |
Nicolaides-Baraitser syndrome, Nicolaides-Baraitser syndrome |
| RS886041046 |
SMAD3
|
Health Risk |
Likely pathogenic |
Aneurysm-osteoarthritis syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS886041048 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS886041049 |
MAP3K1
|
Health Risk |
Likely pathogenic |
46, XY sex reversal 6 |
| RS886041050 |
AR
|
Health Risk |
Likely pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS886041051 |
LRSAM1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS886041052 |
TRAPPC11
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type R18, Autosomal recessive limb-girdle muscular dystrophy type R18 |
| RS886041053 |
TRAPPC11
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type R18, Autosomal recessive limb-girdle muscular dystrophy type R18 |
| RS886041054 |
GNB5
|
Health Risk |
Pathogenic |
Gnb5-related intellectual disability-cardiac arrhythmia syndrome, Gnb5-related intellectual disability-cardiac arrhythmia syndrome |
| RS886041055 |
GNB5
|
Health Risk |
Likely pathogenic |
Gnb5-related intellectual disability-cardiac arrhythmia syndrome, GNB5-related disorder |
| RS886041056 |
GLDN
|
Health Risk |
Pathogenic |
Lethal congenital contracture syndrome 11, Lethal congenital contracture syndrome 11 |
| RS886041057 |
GLDN
|
Health Risk |
Pathogenic |
Lethal congenital contracture syndrome 11, Lethal congenital contracture syndrome 11 |
| RS886041058 |
MBOAT7
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal recessive 57 |
| RS886041059 |
MBOAT7
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 57 |
| RS886041060 |
MBOAT7
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 57 |
| RS886041061 |
MBOAT7
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 57 |
| RS886041062 |
NAXE
|
Health Risk |
Conflicting classifications of pathogenicity |
Encephalopathy, progressive |
| RS886041063 |
NAXE
|
Health Risk |
Pathogenic |
Encephalopathy, progressive |
| RS886041064 |
NAXE
|
Health Risk |
Pathogenic |
Encephalopathy, progressive |
| RS886041065 |
ASXL2
|
Health Risk |
Pathogenic |
Shashi-Pena syndrome, Shashi-Pena syndrome |
| RS886041066 |
ASXL2
|
Health Risk |
Pathogenic |
Shashi-Pena syndrome, Shashi-Pena syndrome |
| RS886041067 |
ASXL2
|
Health Risk |
Pathogenic |
Shashi-Pena syndrome, Shashi-Pena syndrome |
| RS886041068 |
ASXL2
|
Health Risk |
Pathogenic |
Shashi-Pena syndrome, Shashi-Pena syndrome |
| RS886041069 |
ASXL2
|
Health Risk |
Pathogenic |
Shashi-Pena syndrome, Shashi-Pena syndrome |
| RS886041070 |
ASXL2
|
Health Risk |
Pathogenic |
Shashi-Pena syndrome, Shashi-Pena syndrome |
| RS886041075 |
SCARB2
|
Health Risk |
Pathogenic |
Action myoclonus-renal failure syndrome, Progressive myoclonic epilepsy |
| RS886041076 |
SCARB2
|
Health Risk |
Pathogenic |
Action myoclonus-renal failure syndrome, Progressive myoclonic epilepsy |
| RS886041077 |
SCARB2
|
Health Risk |
Pathogenic |
Action myoclonus-renal failure syndrome, Action myoclonus-renal failure syndrome |
| RS886041078 |
SCARB2
|
Health Risk |
Pathogenic |
Action myoclonus-renal failure syndrome, Progressive myoclonic epilepsy |
| RS886041080 |
SLC25A4
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive |
| RS886041081 |
SLC25A4
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant |
| RS886041082 |
SLC25A4
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant |
| RS886041083 |
INS
|
Health Risk |
Conflicting classifications of pathogenicity |
Diabetes mellitus, permanent neonatal 4 |
| RS886041084 |
TBCD
|
Health Risk |
Pathogenic |
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome, Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome |
| RS886041085 |
TBCD
|
Health Risk |
Pathogenic |
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome, Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome |
| RS886041086 |
TBCD
|
Health Risk |
Pathogenic |
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome, Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome |